Brief: Hofseth Biocare Q2 operating loss widens to NOK 47.5 million
Aug 29 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* Q2 operating revenue 8.2 million Norwegian crowns ($989,848) versus 6.4 million crowns
year ago
* Q2 operating loss 47.5 million crowns versus loss 19.1 million crowns year ago
* Expects to recognize significant negative one-off items during q3
Source text for Eikon: ID:nGNE9nR539
Further company coverage: HOFBC.OL
($1 = 8.2841 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering